UR241-2

N/A

Report date: 2023/09/28 17:00:16
NME

Base Information

Drug NameUR241-2
Drug Alias NameUR241-2UR-241-2
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 receptor-associated kinase 1 inhibitorsInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 1Interleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPenn State College of MedicineUniversity of Rochester Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Rochester Medical CenterPenn State College of Medicine
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A